Cascade Pharmaceuticals, Inc.
PrivateLast Round
Series D
Jun 10, 2026
Total Funding Raised
$224.1M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Cascade Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that discovers, develops, and commercializes innovative drugs targeting nuclear receptors and G protein-coupled receptors (GPCRs) for metabolic diseases and inflammation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cascade Pharmaceuticals, Inc. Comparables
Compare Cascade Pharmaceuticals, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Terns Pharmaceutical | 78% | |
| Ascletis Pharma Inc. | 78% | |
| Viking Therapeutics, Inc. | 76% |
Cascade Pharmaceuticals, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jun 10, 2026 | ||||
| VC Round | Feb 11, 2026 | ||||
| Series C | Feb 10, 2026 | ||||
| Series B | Nov 28, 2025 | ||||
| Series A | Jun 5, 2025 | ||||
Series A | Aug 11, 2023 |
Cascade Pharmaceuticals, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Qingdao Guoxin Venture | VC Round, Series C |
| China Life Capital | VC Round, Series C |
| Shanghai Guotou Pioneer Private Equity Fund Management | Series C |
| Guokejiahe Fund | Series A |
| Lapam Capital | Series A |
| Jiuyou Capital | Early Funding |
| China Science and Technology Industry Investment Management | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 10, 2026
$72M round led by Zhongping Capital.
- Aug 11, 2023
$19.4M round with participation from Puhua Capital and PWC Capital.
Cascade Pharmaceuticals, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cascade Pharmaceuticals, Inc.'s valuation, stock price, and market status.
Is Cascade Pharmaceuticals, Inc. a public or private company?
Cascade Pharmaceuticals, Inc. is a private company.
What is the current stock price of Cascade Pharmaceuticals, Inc.?
Cascade Pharmaceuticals, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Cascade Pharmaceuticals, Inc. worth (valuation)?
Valuation information for Cascade Pharmaceuticals, Inc. is not publicly available.
Can I buy Cascade Pharmaceuticals, Inc. stock?
Cascade Pharmaceuticals, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cascade Pharmaceuticals, Inc.'s last funding round?
Cascade Pharmaceuticals, Inc.'s most recent funding round was VC Round on February 11, 2026.
Who are the main investors in Cascade Pharmaceuticals, Inc.?
Key investors in Cascade Pharmaceuticals, Inc. include Zhongping Capital.
Will Cascade Pharmaceuticals, Inc. IPO soon?
No public IPO plans have been announced for Cascade Pharmaceuticals, Inc..
How can I track Cascade Pharmaceuticals, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cascade Pharmaceuticals, Inc.'s secondary market activity and sign up for updates.